ROYAL BANK OF CANADA - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$24,000
+242.9%
12,034
+475.8%
0.00%
Q1 2021$7,000
+40.0%
2,090
+57.1%
0.00%
Q4 2020$5,000
+150.0%
1,330
+90.0%
0.00%
Q3 2020$2,0000.0%700
-7.8%
0.00%
Q2 2020$2,000
+100.0%
759
-4.2%
0.00%
Q1 2020$1,000
-94.1%
792
-66.7%
0.00%
Q4 2019$17,000
+466.7%
2,375
+217.9%
0.00%
Q3 2019$3,000
-66.7%
747
-19.2%
0.00%
Q2 2019$9,000
+12.5%
925
+32.1%
0.00%
Q1 2019$8,000
-20.0%
700
-22.8%
0.00%
Q4 2018$10,000
-50.0%
907
-22.7%
0.00%
Q3 2018$20,000
+53.8%
1,173
+58.3%
0.00%
Q2 2018$13,0007410.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,950,949$1,092,0000.45%
AMERICAN FINANCIAL GROUP INC 1,480,000$829,0000.25%
Vanguard Capital Wealth Advisors 158,900$86,0000.06%
Atom Investors LP 113,151$63,0000.03%
Nantahala Capital Management 774,767$434,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,173,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$659,0000.01%
Altshuler Shaham Ltd 1,088,848$609,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 309,400$173,0000.00%
Clal Insurance Enterprises Holdings Ltd 585,000$328,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders